Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.2, 2006-02, pp. : 225-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2209-2220

Informa Healthcare

Access to resources Recommend Favorite

Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary artery

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1431-1434

Informa Healthcare

Access to resources Recommend Favorite

A polymer-free, sirolimus-eluting stent is as effective as a standard, polymer-based, paclitaxel-eluting stent in the prevention of coronary artery restenosis

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Sirolimus- top paclitaxel-eluting stents in small-vessel disease

Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Hypersensitivity with sirolimus and paclitaxel drug-eluting stents

Reactions Weekly, Vol. 1, Iss. 1088, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite